Background: After the completion of the human genome sequencing project human genetics has now shifted its focus to DNA variation. DNA variation analysis is considered to be a key in partly understanding the mechanisms of complex diseases or varying patient responses in drug treatment. One of the major goals in genetics is finding the DNA variants that can act as diagnostic markers for predisposition to specific diseases. Moreover, in microbiology DNA variation has long been known to help discriminate and identify bacterial strains and viruses. Diagnostics based on DNA or RNA detection might be advantageous as an early-stage indication can be provided. Methods: Many simple and efficient methods for the analysis of nucleic acids are already available. Consequently, the last few years have seen an increased in the use of large-scale analysis of nucleic acids, in basic DNA variation studies along with diagnostics. Mass spectrometry techniques such as matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI) can be of great use for genome variation analysis. In particular high-throughput SNP analysis by MALDI can be performed using fully integrated platforms. Conclusions: Mass spectrometry-based procedures have promise for SNPs analysis especially for clinical diagnostics. D
DNA variation analysis enters a new stage of research. Many projects in current human genetics aim to dissect complex traits by making use of DNA markers, mainly by single nucleotide polymorphisms (SNPs) [1] . Currently, around 10 million SNPs are stored in public databases. In general, in diploid organisms as humans SNPs are biallelic polymorphisms meaning base substitutions, occurring at least once per 300-1000 bp, with the minor allele occurring at least for 1% in a population -otherwise they are termed point mutation. Although single base deletions and insertions are not strictly SNPs, they are commonly included in this definition. SNPs are currently being used as genetic markers, primarily for whole-genome scanning of genomes to gain first indication of interesting regions that contribute to the traits under investigation or in more focused candidate gene association studies [2, 3] . Many SNP-based studies are still at their early stages and it is not yet clear how far SNP genotyping can eventually contribute to the genetic dissection of (complex, polygenic) traits [4] . Once an SNP or a group of SNPs has been identified as a disease marker, it can be used for diagnostics. Thus, researchers hope that SNP genotyping might in general allow for systematic screening of genetic risk variants in the future and change medicine from case-driven intervention to predictive medicine. Currently, however, only few examples such as for Crohn's disease have been shown [5] . Furthermore, SNPs are currently being used as genetic markers to distinguish related organisms, for example, in forensics, or to specifically detect microorganisms in food or in patient sera.
High throughput methods have been developed for in vitro SNP genotyping in different fields of applications. The (cost-) efficiency of the different methods can in principle be measured by the number of SNPs and DNAs under investigation. Technologies using array-based read-out combined with high-multiplex generation of SNP products such as the Affymetrix 10 or 100 K chips [6] , the Illumina bead arrays [7] or the ParAllele chips [8] are efficient when several thousand SNPs are analyzed in parallel. Solutionbased one-step procedures such as the homogenous 5V-nuclease TaqMani assay [9] using real-time fluorescent detection or MALDI mass spectrometry-based procedures [10] are particularly economical in studies where up to 50 SNPs have to be typed in cohorts of several thousand DNAs.
Many of the SNP typing methods require several steps. Short operational time is desirable because it reduces labor costs. Short reaction sequences become even more important in clinical diagnostics, where rapid analysis can be crucial to save the life of a diseased (e.g., infected) patient. Many of the SNP genotyping techniques are currently being optimized in terms of higher throughput and cost efficiency; however, it seems that the focus is still rather on making SNP genotyping procedures more cost-efficient for fundamental genome research by parallelization and miniaturization of assays [11] rather than simplifying assays for diagnostic routine. While current technology developments thus mainly concentrate on the requirements of research laboratories, in clinics some specific criteria are important that are sketched here: Firstly, a simple and short protocol, which can be easily applied for medium throughput applications, is required. It is less likely in diagnostic laboratories that thousands of different SNPs have to be typed in one individual patient DNA. Rather the repetitive day-to-day analysis of a limited number of SNPs in several thousand DNA samples per day seems more realistic. In a clinical environment, in many cases hospitalization costs become an important issue, which lie in the range of several hundred, if not thousand Euro or US-Dollar per day. Therefore in clinics the raw genotype price is not as important as in a scientific environment. Although the price per genotype is high due to the use of expensive modified oligonucleotide probes, the TaqMani assay [9] is one of the most frequently used techniques in clinical laboratories. This can be explained by its short reaction sequence (basically a one-step procedure requiring about 2 h), and, provided that suitable standards are used for clustering of fluorescence signals, TaqMani results are, in general, sufficiently accurate. Furthermore, fully integrated platforms including assay design and analysis software are available facilitating easy application.
Mass spectrometry
In principle, mass spectrometry-based technologies provide attractive solutions for biomolecule analysis because they can be used for direct and fast detection of proteins, peptides and nucleic acids [12] . No labeling and clustering of signals are required. With mass spectrometry not only one detection platform can be used for many applications but data obtained can be easily scored and handled by automated data management systems. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI -TOF -MS) [13] and electrospray ionization (ESI) mass spectrometry [14] have revolutionized the analysis of nucleic acids and other biomolecules. It has been shown that ESI can be routinely coupled to (liquid) chromatography to provide separation of DNA molecules as well as sample clean-up [15] . ESI can be used to detect large molecules (> 20 kDa) and was applied to analyse small PCR products [16, 17] . However, only a few principles using ESI or related procedures based on atmospheric pressure chemical ionization (APCI) have been developed for SNP detection. The reason for this might be the ionization process that requires very pure samples and does presently not allow for as high-throughput testing as MALDI (described below). Moreover, very sophisticated and expensive instruments such as ESI -FT -ICR (Fourier transform ion cyclotron resonance) mass spectrometers [18] would be the best choice to perform the procedures accurately and with high resolution. Additionally, sequential analysis of many samples per day seems to remain more difficult with these equipments than with robust MALDI -TOF mass spectrometers. Other approaches using ion trap, quadrupole or time-of-flight ESI mass spectrometers focused on generating and detecting small products of SNPs [19] , indirect monitoring of substrates of allele-specific reactions such as primer extension [20] , or analyzing tags such as photolabile groups attached to allele-specific products [21] . Particularly, the method of Kokoris et al. using photolinker chemistry [21] could be powerful in terms of throughput; however, it seems that this approach has been commercialized by Qiagen (Hilden, Germany) with marginal success. The requirement of several molecular biological and purification steps might represent important disadvantages of these procedures. However, since ESI and related methods do presently not allow for as high-throughput and are hence not as widely used as MALDI this review concentrates on MALDI-based technologies for SNP analysis.
Why use MALDI mass spectrometry for analysis of nucleic acids?
A characteristic feature of mass spectrometry is that the detection relies on a physical property (the mass to charge ratio) of target sequences, in contrast to many other methods based on indirect detection making use of fluorescent or more old-fashioned radioactive reporter tags. Mass analysis can contribute to highly accurate data [10] . The sensitivity limitation of available MALDI mass spectrometers is in the range of¨1 fmol per analyte. Current MALDI instruments are capable of recording about 1 analysable mass spectrum and due to the fact that MALDI provides many detection channels it can be used to record as many data points per experiment. In this way multiple DNA products can be analyzed in a single experiment (multiplex analysis). Moreover, due to the chemical nature of nucleic acids, which, in contrast to peptides are rather monotonous molecules virtually displaying no differences in desorption efficiency, quantification is routinely feasible. Based on these features of MALDI -accuracy, high-throughput capability, multichannel detection, and quantificationseveral procedures and software for SNP analysis were successfully introduced; some of them suitable for efficient SNP diagnostics [10, 22] .
Principles of MALDI mass spectrometry
The principle of MALDI is shown in Fig. 1 . Irradiation of co-crystals formed by suitable small and acidic organic molecules, termed the ''matrix'', and biomolecules with a pulsed laser (usually an UV laser) at a wavelength close to a resonant absorption band of the organic (aromatic) molecules induces an energy transfer and desorption process, evaporating matrix and analyte ions into the gas-phase [10, 12, 23] . A common matrix used for nucleic acids is 3-hydroxypicolinic acid [24] . By MALDI predominantly either positively or negatively single charged molecules are observed [25] . The ions are generated by a proton-transfer reaction of matrix and analyte molecules in the gas-phase. After ionization, matrix and analyte molecules are accelerated by an electric field. Usually, MALDI -MS is performed with time-of-flight separation (MALDI -TOF-MS). In this way molecules are guided -with virtually the same kinetic energy -by ion optics into a field-free flight-tube where they are separated by their mass to charge ratios before they finally reach the detector.
The equipment of MALDI mass spectrometers with delayed extraction [26] has greatly improved the resolution of mass signals allowing the distinction of nucleobase substitutions in the range of 1000 -8000 Da, which approximately corresponds to DNA lengths of 3-24 nucleobases. One contributing factor to this limitation is probably the sizedependent tendency of the phosphodiester backbone of the DNA to fragment during the MALDI process, which results in a loss of signal intensity for intact DNA [23] . An additional contributing factor to this restriction could be a bias of MALDI towards smaller DNA oligomers. Interestingly, RNA molecules are more stable in MALDI due to the additional 2V-hydroxyl group that stabilizes the glycosidic bond leading to significantly reduced depurination and fragmentation of the whole oligomer [27] .
The main problem in detecting nucleic acids by mass spectrometry is related to the negatively charged sugarphosphate backbones [10] . Each phosphate linkage provides a site of negative charge in solution so that nucleic acids carry as many negative charges as phosphate bridges. The affinity of the phosphate residues for alkali counterions commonly used in PCR buffers, such as sodium and potassium, is not high enough to result in complete saturation. Salt ions interfere in the ionization process by inducing adducts with nucleic acids, which causes significantly reduced signal intensities. Problems with alkali ions can be alleviated by adding ammonium ions during matrix preparation [28] . However, to satisfactorily solve this problem, stringent purification procedures were introduced for removal of salt ions and detergents that can disturb matrix crystallization. Protocols include use of magnetic bead separation, reversedphase column purification, gel filtration, ion exchange chromatography and ethanol precipitation [10] . Using DNA modification chemistry termed ''charge-tagging'' [29, 30] in the molecular biological procedure for generating products of SNPs, purification could be circumvented by a simplified, one-pot reaction method called the GOOD assay [31 -34] . Applying ''charge-tag'' chemistry, the detection sensitivity is increased¨100-fold compared to unmodified DNA and DNA products as well as peptide nucleic acids [35] are rendered insensitive to impurities in MALDI by conditioning products to carry either a single fixed positive or a single fixed negative charge.
SNP genotyping by MALDI
In the mid-90s, several approaches combined enzymatic Sanger-sequencing or related procedures with MALDI readout to provide an efficient alternative to relatively slow slabgel or capillary-based technology [36, 37] . However, it became apparent that the highlighted problems with MALDI such as limited size range of detection, fragmentation, adduct formation, and resolution severely impeded to accurately and efficiently analyse DNA sequence ladders. This was the reason why molecular biological sample preparation approaches for MALDI have shifted from sequencing to related primer extension reactions; coinciding with the increasing popularity of SNPs as markers in human genetics. Primer extension has -not only in mass spectrometry -become one of the most widely used procedures for the generation of products of SNP because it is robust, flexible, easy to design and, what is crucial for MALDI, it generates products with masses of around 5000 -8000 Da that can be easily detected [10, 38] . The principle of the procedure is shown in Fig. 2 . A reaction of a PCR product with an extension primer that is chosen upstream of the SNP under investigation, ddNTPs (and optionally dNTPs), and a thermostable DNA polymerase yields allele specific products. The polymerase extends the 3V-end of the primer by specifically incorporating nucleotides that are complementary to the DNA template. The extension reaction terminates at the first nucleobase in the template where a nucleotide occurs that is complementary to one of the ddNTPs in the reaction mix. A thermostable DNA polymerase employed in a temperature-cycled reaction leads to linear amplification of the extended primers. As several steps are required for all of these procedures, operational time becomes an important issue. It can be estimated that all these assays would require about 6 h for sample preparation prior to analysis.
Primer extension reaction approaches enable a limited degree of multiplexing. In general, 3 -5 SNPs can be routinely typed in parallel. However the quality of enzymatic reactions in multiplex assays strongly depends on the SNPs that have to be combined. Surrounding DNA sequences can significantly influence the quality of the PCR and primer extension. In contrast to basic epidemiological studies, it is likely that the same SNPs have to genotyped many times in diagnostics. In this case investing some time for optimisation of multiplexed assays seems to be worthwhile.
Sequenom (San Diego, CA; http://www.sequenom.com) offers a complete commercially available solution for highthroughput MALDI-based SNP genotyping by primer extension termed MassARRAYi. The Sequenom package includes assay design software, reagents, liquid handling, detection, and data analysis. A unique feature is the use of piezoelectric pipetting of nanoliter quantities of SNP products onto SpectroCHIPSi covered with matrix spots. These chips, which are not recyclable, do significantly contribute to the cost. Current prices for a chip covered with 384 matrix spots lie in the range of about 200 C or 260 US$. Therefore, the multiplexing of genotyping assays at the level of PCR and primer extension is proposed to lower costs deriving from the chips. Another commercially available method is the recent GenoSNIPi assay [39] from Bruker Daltonics (Leipzig, Germany; http://www.bdal.com).
Many alternative methods based on PCR, primer extension and MALDI have been developed but are not available as complete integrated systems. Significantly more efforts are required to implement such procedures in a laboratory. However, the implementation of MALDI-based SNP assays, including the PinPoint assay [40, 41] , the VSET (very short extension) assay [42] , the purification-free GOOD assay [31 -34] or related assays [43] , is feasible and could lead to more cost-effective analysis of SNPs than the commercially available methods. Recently, MALDI assays were introduced using biotinylated ddNTPs in the extension reaction and solid-phase capturing to provide an enrichment of primer extension products during the purification step [44, 45] . This approach results in a higher degree of multiplexing. However, all mentioned assays require several steps. Therefore much more operational time is needed than in competing assays such as TaqMani. Future developments of mass spectrometric SNP typing methods should focus on shortening and simplifying reaction sequences [46] . Such improvements can be crucial for diagnostic applications in clinical practice.
Quantification
It was postulated that several hundred thousand SNPs are required to detect subtle effects of DNA variations in complex diseases [2] . That would represent an enormous task for a SNP typing laboratory including unreasonably high costs. Therefore pooling of DNA samples has been suggested as a strategy to decrease the number of genotypes necessary for large-scale association studies. The principle of the procedure is shown in Fig. 3 . A crucial point of this approach is the preparation of well-defined mixtures of different individual DNAs.
The MassARRAYi system from Sequenom has been used in a study to analyse allele frequencies of about 9000 gene-based SNPs in DNA pools of 95 individuals [47] . In this study high reproducibility of T 1.6% for alleles with a frequency > 10% was achieved. The deviation of the detected allele frequencies (about 0.7%) was checked by comparison of genotypes measured in pooled DNA and for individual DNAs.
A pooling approach, combined with Sequenom technology to determine allele frequencies in case and control populations, was also shown by Werner et al. [48] . The accuracy and reliability of the procedure was determined in pools of eight previously genotyped individuals. The allele frequencies were in the range of 0.1 to 0.9. The accuracy of detected SNP allele frequencies was also demonstrated using DNA pools of 142 to 186 individuals and typing for additional markers. Allele frequencies observed in the pooled samples deviated from the real frequencies by about 3%.
Shifman et al. compared MALDI-based technologies with restriction fragment length polymorphism, real-time pyrophosphate DNA sequencing, single base extension with fluorescently labeled ddNTPs, and the TaqMani assay to evaluate their applicability to perform accurate SNP allele frequency determination in samples of pooled DNA [49] . The authors concluded that although the procedures slightly differ in accuracy, they all could be used for quantification of SNP allele frequencies in DNA pools.
In a nutshell, the combination of pooled DNA and primer extension-based MALDI assays provides a cost-and timeefficient method if common alleles are in the focus of the researcher's interest.
Applications
Primer extension and MALDI mass spectrometry can be most efficiently applied to a limited number of SNPs (< 50) in large DNA cohorts. Numerous candidate gene association studies and even whole genome scans, diagnostic assays including bacterial and viral genotyping, and SNP typing in (breeding and model) animals and plants have been published in the last years, which used MALDI as detection tool. Technically, most of such studies relied on the Sequenom system. However, any other mentioned alternative MALDI procedure is principally suitable for such studies. In this section, I present two examples in which MALDI SNP typing has been used in a candidate gene and in a regional genome scan approach.
SNPs in ADAM33 were found to be associated with asthma and related traits in two German populations [50] . The transmission disequilibrium test (TDT) was applied for association analysis in a family-based study. Additionally, association tests of SNPs were carried out in case-control DNA cohorts. Both approaches revealed SNPs that were significantly associated with asthma and related traits. This study replicated a more recently published association between asthma and ADAM33 gene variants. Unfortunately, most of the associated SNPs were found at non-identical positions in different population samples impeding their use in diagnostics.
The same group investigated allele frequencies using pooled DNA from individuals suffering from asthma, Crohn's disease (CD), schizophrenia, type 1 diabetes (T1D), and controls of healthy patients [51] . In this study 534 SNPs were selected spanning a 25-Mb region on chromosome 6p21. One of the key conclusions of the authors was that the analysis of SNP allele frequencies in pooled DNA is a valuable procedure to assign genotyping priorities in large regions of linkage.
Molecular haplotyping
In diploid organisms such as humans, looking at the haplotype of SNPs -the pattern of alleles on a single chromosome -can be more informative than just looking at single SNPs [52] . Interacting SNPs can represent more powerful markers; moreover, haplotypes reflect the sequence and eventually the structure of a transcribed protein. This is one of the reasons why haplotypes have become interesting in fields such as pharmacogenetics. For n heterozygous SNPs, 2 n haplotypes are possible. Although the theoretically maximal number is rarely found, it can often be too large to accurately infer a haplotype from SNP alleles. Haplotypes can be deduced using SNP genotype data and applying computer programs that are build on a number of different algorithms. However, these programs have a limited degree of accuracy; statistical uncertainty particularly arises when many heterozygous SNPs occur in close proximity. The uncertainty associated with computational haplotyping is unacceptable in diagnostics. Molecular (direct) procedures that rely on the separation of parts or whole chromosomes are more accurate alternatives to determine the haplotype. Many methods have been introduced to directly detect the haplotype by wet-lab methods including mass spectrometry. As previously described, mass spectrometry has the advantage that several SNPs can be analyzed at the same time (multiplex detection). Mass spectrometry approaches, such as the Sequenom technology or the GOOD assay, can be converted to a haplotyping procedure by using either single molecule PCR amplification, allele-specific PCR, or cloning procedures in the first step. The three different procedures are illustrated in Fig. 4 .
Single molecule PCR amplification of diploid genomic DNA is a feasible strategy to generate haploid DNA for subsequent primer extension reactions. Such a procedure necessitates DNA samples that are diluted to a single copy. This haplotyping method is principally limited by the size of the DNA fragments. In many methods for isolation of genomic DNA, fragments of about 25 kb are frequently seen. This can impede efficient analysis of haplotypes over tens of kilobases. In practice, contamination problems can represent an additional significant drawback, particularly in clinical practice. A proof-of-principle study of the approach described here has been shown with the Sequenom technology [53] .
Allele-specific PCR amplifies one allele of a heterozygous SNP and thereby a haploid piece of human DNA. The following steps for SNP allele scoring can be similar to mentioned primer extension-based genotyping assays. A proof-of-principle study of this approach including multiplex analysis of SNPs was shown using the GOOD assay [54] . In this procedure, molecular haplotypes are monitored by looking at SNP alleles that are correlated with the allele-specific PCR. However, this method could be limited by the size of PCR products. Haplotyping using this approach has been shown on PCR products of about 1000 bp. Long-range haplotyping over several kilobases would require cumbersome walking from one fragment to the adjacent fragment. Recently, we have developed a molecular haplotyping method in which the alleles of SNPs are statistically separated by a cloning approach using a pooling strategy and subsequently determining the phase of SNPs by multiplexed GOOD assays [55] . We have termed the procedure ''Clone-based Systematic Haplotyping'' (CSH). This method is particularly valuable when studying several genes in parallel or large genomic regions (> 30 kb). Therefore it is more likely that this method will rather be used in basic studies than in diagnostics.
Re-sequencing
Recently, some related procedures for re-sequencing DNA using MALDI have been reported [56, 57] . All of these methods make use of the accurate multichannel detection capability of MALDI. As is shown in Fig. 5 , the procedures rely on the analysis of base-specific fragments. The fragments are produced by initially performing PCR with a primer tagged with a 5V-tail containing for example a T7 or SP6 promoter site for RNA polymerase. In the next step the PCR product serves as template for transcription into RNA. To increase information content, usually sense and antisense transcription is performed. However, there is one considerable drawback: RNA polymerases used for transcription do not have 3V -5V proof reading activity, which can increase false nucleotide incorporation. Several related RNA transcription protocols using natural or modified pyrimidine nucleotides that resist subsequent hydrolysis by RNases have been introduced. After transcription the RNA is specifically fragmented by base-specific hydrolysis using RNases such as RNase T1 (G-specific), RNase U2 (A-specific) or RNase A (C-and U-specific). Differences between the masses obtained for the sample under investigation and an in silico digested reference sequence allow finding sequence variations such as SNPs. The technology described here is available from Sequenom.
A similar approach was applied to bacterial identification using the 16S rRNA gene (16S rDNA) [58] . Base-specific fragmentation of PCR products using uracil-DNA-glycosylase was combined with MALDI detection. 16S rDNA signature sequences were amplified by PCR from bacteria in the presence of dUTP instead of dTTP. The PCR products were subsequently immobilised onto a solid surface coated with streptavidin to selectively produce either sense or antisense templates. Single-stranded amplicons were then treated with uracil-DNA-glycosylase to generate T-specific abasic sites and fragmented by alkaline treatment. The resulting fragment patterns were analyzed applying the same principles as described above. This procedure enabled the characterization of cultured and as-yet-uncultured bacteria.
Chemical cleavage is an alternative to enzymatic approaches. In an interesting non-enzymatic base-specific cleavage approach with primer extension products, acidlabile phosphoramidite bonds replace the 5V phosphodiester bonds of newly incorporated pyrimidine nucleotides [59] . Sequence variations as SNPs are observed by specific hydrolysis of the acid-labile bonds of the incorporated nucleotides and MALDI analysis of the resulting fragments. The analysis of genomic targets ranging from 100 to 450 bp in length is possible.
The methods described for re-sequencing might be particularly useful for discovery of new SNPs and in bacterial fingerprinting. Recently, researchers at Epigenomics (Berlin, Germany; http://www.epigenomics.com) have shown that these procedures can also be used to quantitatively analyse DNA methylation in the human genome [60] . Software is available for the interpretation of complex mass spectra obtained by described RNase-based approaches [61] . However, it seems that there are some caveats in these resequencing approaches. In the low mass range, mass signals usually do not differ well from each other, no matter which sequence is under investigation. Additional information can be gained from larger fragments (> 10 bases) but in this mass range signals have lower quality in terms of sensitivity and resolution. A further problem could be that not all products of the RNase digestion can be detected by MALDI due to interference in the desorption/ionization process, or it might occur that the RNase digestion is not as efficient as expected.
Conclusions
Mass spectrometers, particularly those based on MALDI, are mature and stable instruments that can be efficiently applied for SNP analysis. Jurinke et al. have recently highlighted the wide application range of MALDI in genetics; as it can be used for SNP discovery and genotyping, molecular haplotyping, methylation analysis, and RNA and allele-specific expression [62] .
Many different molecular biological procedures for the generation of SNP products have been coupled to MALDI mass spectrometry. Currently, those based on primer extension reactions are mostly used for candidate gene association studies and in pharmacogenetics. More recent approaches developed for re-sequencing exploit the multichannel detection capability of MALDI mass spectrometers. These approaches are presently transferred, for example, to enable fingerprinting of bacteria.
While MALDI technologies are cost-effective when applied in multiplex applications, these approaches have one drawback in clinical environment: they require multiple steps and hence generally too long operational time. Future developments focusing on detection of PCR products with novel MALDI mass spectrometers are sought-after to overcome current limitations discussed in this article. One promising approach in this regard consists of the development of novel sample preparation and MALDI ionization techniques as well as improved detection devices to improve mass signal resolution and to enable detection of analyte molecules being significantly larger than 100 kDa. Research efforts in the mass spectrometry community should focus on this issue.
In the past, technology development for the analysis of SNPs mainly focused on in vitro procedures. Future efforts will also include the specific analysis of nucleic acids at the low to sub-zeptomole level in cells or tissues, either in situ or in vivo [11] .
A remaining issue, which has not fully been addressed in this review, concerns possibilities of quality control and certification of mass spectrometry-based procedures for clinical diagnostics. To my knowledge, so far no DNA mass spectrometry assay has been approved by the FDA. However, since MALDI provides accurate detection of the mass of SNP products and does not rely on clustering methods, it might become an interesting diagnostic tool in the future.
